NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
08 janv. 2024 09h43 HE
|
NeuroMetrix, Inc.
NeuroMetrix announced today that the Company’s Chairman and CEO, Dr. Shai N. Gozani will present at the Emerging Growth Conference on January 10, 2024.
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)
12 déc. 2023 09h00 HE
|
NeuroMetrix, Inc.
NeuroMetrix reported the recent presentation of data from a clinical trial of Quell wearable neuromodulation technology in patients with Long COVID.
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)
05 déc. 2023 09h00 HE
|
NeuroMetrix, Inc.
NeuroMetrix noted publication of results from a NIH-funded clinical trial of Quell. The paper has been electronically published in The Journal of Pain.
NeuroMetrix Announces One-for-Eight Reverse Stock Split
20 nov. 2023 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00...
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023
30 oct. 2023 09h00 HE
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it will present at the Emerging Growth Conference on Wednesday November 1, 2023 at 3:40PM EDT.
NeuroMetrix Reports Q3 2023 Business Highlights
26 oct. 2023 07h00 HE
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and nine month period ended September 30, 2023.
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call
23 oct. 2023 11h13 HE
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it plans to issue its Q3 2023 business and financial highlights on October 26, 2023 at 8:00 a.m., Eastern Time.
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia
02 oct. 2023 09h00 HE
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced that it has been selected as a Proud Sponsor of the National Fibromyalgia Association (NFA).
NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023
28 sept. 2023 12h19 HE
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it will present at the Emerging Growth Conference on October 4, 2023 at 3:55pm EDT.
NeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023
30 août 2023 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on September 6, 2023. This live,...